Chronic Kidney Disease (CKD) Platelet Study
A Mechanistic Study in Patients With Non-Dialysis Chronic Kidney Disease to Investigate Altered Platelet Response to Antiplatelet Therapy (CKD-Platelet Study)
Sponsor: American Society of Nephrology
A PHASE3 clinical study on Chronic Kidney Diseases and Heart Attack, this trial is completed. The trial is conducted by American Society of Nephrology and has accumulated 14 data snapshots since 2018. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Feb 2023 — Jul 2024 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Oct 2021 — Feb 2023 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Sep 2021 — Oct 2021 [monthly]
Recruiting PHASE3
▶ Show 9 earlier versions
-
May 2021 — Sep 2021 [monthly]
Recruiting PHASE3
-
Jan 2021 — May 2021 [monthly]
Recruiting PHASE3
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Sep 2020 — Dec 2020 [monthly]
Recruiting PHASE3
-
Dec 2019 — Sep 2020 [monthly]
Recruiting PHASE3
-
Dec 2018 — Dec 2019 [monthly]
Recruiting PHASE3
-
Nov 2018 — Dec 2018 [monthly]
Recruiting PHASE3
-
Oct 2018 — Nov 2018 [monthly]
Recruiting PHASE3
-
Sep 2018 — Oct 2018 [monthly]
Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- American Society of Nephrology
- University of Arkansas
For direct contact, visit the study record on ClinicalTrials.gov .